-+ 0.00%
-+ 0.00%
-+ 0.00%

Nykode Therapeutics posts new press release on VB10.NEO data update

PUBT·07/22/2026 12:05:04
Listen to the news
Nykode Therapeutics posts new press release on VB10.NEO data update
  • Nykode published a July 22, 2026 update on VB10.NEO, its individualized neoantigen therapy, highlighting new preclinical and clinical immunogenicity data.
  • Manufacturing turnaround-time cut to under six weeks from biopsy to release, with a stated path to further reductions via in-house consolidation.
  • Post-hoc analysis linked stronger de novo immune responses with improved overall survival in patients with low baseline immunogenicity.
  • Company flagged VB10.NEO as partnership-ready; poster link: https://nykode.com/research-and-development/scientific-papers-and-presentations/.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nykode Therapeutics AS published the original content used to generate this news brief on July 22, 2026, and is solely responsible for the information contained therein.